Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 30, 2019

SELL
$3.89 - $6.11 $229,144 - $359,915
-58,906 Closed
0 $0
Q3 2018

Nov 08, 2018

SELL
$3.92 - $5.58 $22,861 - $32,542
-5,832 Reduced 9.01%
58,906 $328,000
Q2 2018

Aug 08, 2018

BUY
$3.88 - $5.16 $33,414 - $44,437
8,612 Added 15.34%
64,738 $254,000
Q1 2018

May 15, 2018

BUY
$4.05 - $5.69 $33,671 - $47,306
8,314 Added 17.39%
56,126 $264,000
Q4 2017

Feb 08, 2018

BUY
$4.13 - $6.68 $20,616 - $33,346
4,992 Added 11.66%
47,812 $197,000
Q3 2017

Nov 02, 2017

BUY
$5.36 - $6.37 $67,418 - $80,121
12,578 Added 41.59%
42,820 $271,000
Q4 2016

May 14, 2018

BUY
N/A
30,242
30,242 $210,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $1B
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.